MySmartHeart closes the data- gap

Datenlücke

The MySmartHeart approach accommodates long testing periods and closes technical gaps present in other systems involving multiple wires connected to implanted sensors.

With the MySmartHeart approach, cardiologists have the ideal service for detecting cardiac arrhythmia and following up on catheter ablation.

Examples include:

  • Atrial fibrillation (cryptogenic strokes)
  • Unclear palpitations and tachycardia
  • Causes of syncopes
  • Follow-up to catheter ablation

Your advantages as a cardiologist

MySmartHeart-Service: sicher, einfach und rentabel
Try it out now for free

Reporting

Testing procedure

  1. Clinic/office registers the patient in the service portal.
  2. Clinic/office distributes the ECG sensors and return box to you – or the kit is directly shipped to the patient.
  3. Upon the patient’s consent, MySmartHeart takes over patient support and ensures data quality.
  4. When the testing period is over, the patient returns the ECG sensors to MySmartHeart.
  5. When the testing period is over, the physician/ECG specialist receives the report and is allowed to access the data in the ECG portal.

Case studies

Case report 1: A 64-year-old male

Reason for testing: Atrial fibrillation

Frequency of symptoms: sporadic, not daily

Testing period: 9 days and 10 days (two measurements)

The patient had been previously treated for paroxysmal atrial fibrillation by means of catheter ablation. Six months following the ablation, he was observed for nine days by means of MySmartHeart in the context of routine follow-up. We were able to diagnose atrial fibrillation over two multiple-hour phases. The diagnosis led to a re-ablation. In the second ten-day follow-up, it was possible to determine that there was no atrial fibrillation following the re-ablation.

1. Testing: Distribution of the atrial fibrillation across the entire testing period

2. Diagnosis: no atrial fibrillation during the testing period (10 days). Re-ablation successful

Case report 2: An 83-year-old female

Reason for testing: Syncope

Frequency of symptoms: sporadic, not daily

Testing period: 7 days The patient was referred by the general practitioner.

For some time, she had complained about the sudden occurrence of brief dizzy spells and tightness in the chest. In the clinic, an initial ECG with 12 discharges indicated a bradycardia sinus arrythmia. With measurement using MySmartHeart, it was possible to record sinus pauses and bradycardia. The patient was also instructed to press the patient marker when she experienced the symptoms. The marked events correlated with sinus pauses A short while later, she underwent heart pacemaker implantation.

High patient acceptances over 7 days: only a few hours without record entries

Commentary by attending cardiologist

Case report 3: A 73-year-old female

Reason for testing: Palpitations

Frequency of symptoms: every 1 to 2 weeks

Testing period: 2 weeks planned, aborted after 2 days

The patient came to us because she suffered from sudden massive heart palpitations linked to presyncopal episodes. After two days, the patient suffered a strong symptomatic tachycardia.. Through remote consultation of the transmitted data (PLUS system), it was immediately possible to diagnose supraventricular tachycardia with frequencies up to 220 bpm. An AV nodal reentry tachycardia was confirmed through an electrophysiology study and was successfully ablated.

It was possible to bring the test to early termination since the event that had been sought was found

Comments by the MySmartHeart ECG technician 

Case example 1
Case example 1
Case example 2
Case example 2
Case example 3
Case example 3

Specialised article

Deep Learning For Comprehensive Annotation
Deep Learning For Comprehensive AnnotationQuelle: Benjamin A. Teplitzky, PhD,* Michael McRoberts, MS,* Hamid Ghanbari, MD, FHRS†
Poster zu DNN Algorithmen
Poster zu DNN AlgorithmenQuelle: Preventice Technologies
UK BIOBANK FÜHRT DIE GRÖSSTE STUDIE IN BILDGEBUNG FÜR HERZ UND GEHRIN MIT 30'000 ANWENDER MIT PREVETNICE UND MYSMARTHEART IN UK DURCH
UK BIOBANK FÜHRT DIE GRÖSSTE STUDIE IN BILDGEBUNG FÜR HERZ UND GEHRIN MIT 30'000 ANWENDER MIT PREVETNICE UND MYSMARTHEART IN UK DURCHQuelle: Preventice Technologies
A wearable remote monitoring system for the identification of subjects with a prolonged QT interval or at risk for drug-induced long QT syndrome
A wearable remote monitoring system for the identification of subjects with a prolonged QT interval or at risk for drug-induced long QT syndromeQuelle: Preventice Technologies
Healthcare and Remote Monitoring System Solutin on the Cloud Our Clinical Experience on 100 Patients
Healthcare and Remote Monitoring System Solutin on the Cloud Our Clinical Experience on 100 PatientsQuelle: Preventice Technologies
Efficacy of telemedical interventional management in patients with heart failure
Efficacy of telemedical interventional management in patients with heart failureQuelle: Preventice Technologies
Recommendation from ISHNE and HRS for Patch-EKG-Holter, 2017
Recommendation from ISHNE and HRS for Patch-EKG-Holter, 2017Quelle: https://doi.org/10.1111/anec.12447
We recommend the following Passages:
Table 2, Page 6
Table 3, Page 6
Section 11: Conclusions and Recommendations, Pages 29 and 30
Remote electrocardiograph monitoring using a novel adhesive strip sensor: A pilot study
Remote electrocardiograph monitoring using a novel adhesive strip sensor: A pilot studyQuelle: https://doi.org/10.4330/wjc.v8.i10.559

Information packet order/test kit

Test Kit Icon

Order test kit:

I would like to schedule an appointment for a free 6-week test.

Infopaket Icon

Order information packet:

I would like to receive the «Holter 2.0» information packet for cardiologists.